The government has organized a trade advisory council to address the trade issues that may arise from the National Biotechnology and Biomanufacturing Initiative that the Biden administration launched via an Executive Order. Through the council, the government plans to strengthen communication with the pharmaceutical and bio industry and promptly respond to rising issues.

The advisory council, which consists of trade experts, will hold regular meetings every quarter and actively collect industry opinions to reflect on trade policies established in the healthcare and the pharmaceutical industry.

Until a specific plan is set to regulate the pharmaceutical and bio industry by the US governm